S'abonner

The Prevalence of Nonalcoholic Fatty Liver Disease and Its Risk Factors in Children and Young Adults with Type 1 Diabetes Mellitus - 22/02/21

Doi : 10.1016/j.jpeds.2020.10.043 
Janejira Sae-wong, MD 1, Bundit Chaopathomkul, MD 2, Teerasak Phewplung, MD 2, Nataruks Chaijitraruch, MD, PhD 3, , Taninee Sahakitrungruang, MD 1
1 Division of Endocrinology, Department of Pediatrics, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand 
2 Department of Radiology, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand 
3 Faculty of Medicine, Division of Gastroenterology, Department of Pediatrics, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand 

Reprint requests: Nataruks Chaijitraruch, MD, PhD, Faculty of Medicine, Division of Gastroenterology and Hepatology, Department of Pediatrics, Chulalongkorn University, 1873 Rama 4 Road, Pathumwan, Bangkok 10330, Thailand.Faculty of MedicineDivision of Gastroenterology and HepatologyDepartment of PediatricsChulalongkorn University1873 Rama 4 RoadPathumwanBangkok10330Thailand

Abstract

Objectives

To determine the prevalence of nonalcoholic fatty liver disease (NAFLD) and its associated risk factors in children and young adults with type 1 diabetes (T1D).

Study design

A cross-sectional study was conducted at a tertiary care center in children and young adults with T1D. Liver fat quantification and hepatic fibrosis were assessed by magnetic resonance imaging proton density fat fraction and magnetic resonance elastography (MRE). Logistic regression analysis was performed to examine the associated risk factors for NAFLD.

Results

Fifty patients with T1D (28 females, 13 with overweight/obesity) were included. The median age and duration of T1D were 16.9 years (IQR, 13.6-20 years) and 6.5 years (IQR, 4-11 years), respectively. The prevalence of NAFLD was 10%. Four out of 5 patients with NAFLD were overweight/obese, and 2 had an and elevated alanine aminotransferase (ALT) level. None had liver fibrosis (defined as MRE >2.9 kPa). Compared with patients without NAFLD, patients with NAFLD had significantly higher body mass index standard deviation score (BMI-SDS) (median, 0.94 [IQR, 1.30-2.62] vs 0.13 [IQR, −0.69 to 0.84]; P = .01), ALT (median, 17 IU/L [IQR, 16-52 IU/L] vs 12 IU/L [IQR, 10-14 IU/L]; P = .02), and lower high-density lipoprotein cholesterol (median, 49 mg/dL [IQR, 41-51 mg/dL] vs 57 mg/dL [IQR, 52-69 mg/dL]; P = .039). Multivariate logistic regression analysis identified high BMI-SDS as the sole independent risk factor associated with NAFLD (OR, 5.79; 95% CI, 1.04-32.18).

Conclusion

The prevalence of NAFLD in children and young adults with T1D was comparable to that in the general population. Our study suggests that routine screening for NAFLD in patients with T1D might not be necessary but should be performed in those patients with T1D who are overweight/obese.

Le texte complet de cet article est disponible en PDF.

Keywords : hepatic steatosis, magnetic resonance imaging, proton density fat fraction

Abbreviations : ALT, AST, BMI-SDS, GGT, HbA1c, HDL-c, LDL-c, MRE, MRI, NAFLD, PDFF, T1D, T2D


Plan


 Supported by the Ratchadapiseksompotch Fund (RA 62/094, to T.S.), Faculty of Medicine, Chulalongkorn University. The funder did not participate in the conduct of the study; study design, collection, analysis and interpretation of the data; or preparation of the manuscript for submission. The authors declare no conflicts of interest.


© 2020  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 230

P. 32 - mars 2021 Retour au numéro
Article précédent Article précédent
  • 50 Years Ago in The Journal of Pediatrics : Diazoxide-Induced Hyperosmolar Nonketotic Coma: Contemporary Genetic Insights
  • Lauren E. Boudreau, James F. Padbury
| Article suivant Article suivant
  • Treatment of Chronic Hepatitis C in Young Children Reduces Adverse Outcomes and Is Cost-Effective Compared with Deferring Treatment to Adulthood
  • Emma Greenaway, Alexander Haines, Simon C. Ling, Murray Krahn

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.